| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||||
-1,364 | 914 | 1,060 | 1,830 | 2,023 | 1,283 | 213 | 1,327 | 510 |
Adjustments to reconcile earnings to net cash provided by operating activities: | ||||||||
Depreciation, Depletion and Amortization | ||||||||
882 | 865 | 844 | 842 | 840 | 794 | 799 | 829 | 824 |
Deferred income tax (recovery)/expense | ||||||||
-713 | 173 | 174 | 374 | 435 | -97 | 277 | -181 | -147 |
Unrealized Gain (Loss) on Derivatives | ||||||||
-1,556 | 746 | -107 | 574 | 538 | -584 | 230 | -289 | -260 |
Earnings from equity investments | ||||||||
-163 | -344 | -333 | -413 | -413 | -433 | -378 | -363 | -335 |
Distributions from equity investments | ||||||||
428 | 362 | 535 | 441 | 466 | 449 | 358 | 412 | 320 |
Equity Method Investment, Other than Temporary Impairment | ||||||||
1,736 | - | - | - | 0 | - | - | - | - |
Impairment of long-lived assets | ||||||||
- | - | - | - | - | 28 | 4 | 10 | 1,062 |
Other | ||||||||
-253 | -5 | -15 | -6 | -30 | 9 | 9 | -32 | -78 |
Changes in operating assets and liabilities | ||||||||
-194 | -192 | -228 | 12 | 667 | 28 | 657 | -978 | -622 |
Net cash provided by operating activities | ||||||||
2,809 | 1,993 | 2,735 | 2,494 | 2,176 | 2,503 | 1,461 | 3,344 | 3,194 |
Investing activities | ||||||||
Capital expenditures | ||||||||
1,147 | 1,564 | 1,143 | 1,173 | 1,612 | 2,222 | 1,341 | 1,608 | 1,635 |
Long-term investments and restricted long-term investments | ||||||||
87 | 141 | 318 | 135 | 565 | 221 | 480 | 389 | 222 |
Distributions from equity investments in excess of cumulative earnings | ||||||||
77 | 132 | 17 | 129 | 139 | 34 | 103 | 1,083 | 57 |
Additions to intangible assets | ||||||||
69 | 64 | 36 | 74 | 26 | 49 | 66 | 167 | 258 |
Affiliate loans, net | ||||||||
44 | 82 | 92 | 56 | 84 | 26 | 50 | -10 | 10 |
Net cash (used in)/provided by investing activities | ||||||||
-1,270 | 371 | -1,572 | -1,309 | -2,148 | 55 | 67 | -1,071 | -2,068 |
Financing activities | ||||||||
Net change in short-term borrowings | ||||||||
-63 | -372 | 353 | 46 | -154 | -224 | 237 | 10 | -443 |
Net change in commercial paper and credit facility draws | ||||||||
1,159 | -2,540 | -650 | 1,242 | 2,773 | 102 | -192 | -1,701 | -465 |
Debenture and term note issues, net of issue costs | ||||||||
990 | - | 1,358 | 0 | 1,195 | - | 0 | 1,476 | 2,061 |
Debenture and term note repayments | ||||||||
1,657 | 1,674 | 410 | 795 | 1,789 | 688 | 1,610 | 1,151 | 996 |
Debt extinguishment costs | ||||||||
- | - | - | - | - | - | - | - | 63 |
Contributions from noncontrolling interests | ||||||||
15 | 2 | 1 | 6 | 3 | 1 | 2 | 13 | 8 |
Distributions to noncontrolling interests | ||||||||
76 | 60 | 94 | 54 | 46 | 220 | 212 | 216 | 209 |
Common shares issued | ||||||||
1 | 0 | 0 | 0 | 18 | 4 | 3 | 1 | 13 |
Preference share dividends | ||||||||
96 | 96 | 96 | 101 | 90 | 96 | 94 | 87 | 87 |
Common share dividends | ||||||||
1,641 | 1,493 | 1,504 | 1,490 | 1,486 | 1,226 | 761 | 729 | 764 |
Contributions from redeemable noncontrolling interests | ||||||||
- | - | - | - | - | 8 | 21 | 21 | 20 |
Distributions to redeemable noncontrolling interests | ||||||||
- | - | - | - | - | 61 | 90 | 90 | 84 |
Redemption of preferred shares held by subsidiary | ||||||||
0 | 0 | 0 | 0 | 300 | 210 | 0 | 0 | 0 |
Other | ||||||||
-18 | -11 | -24 | -11 | -25 | -18 | -5 | 0 | 0 |
Net cash provided by/(used in) financing activities | ||||||||
-1,386 | -2,621 | -1,066 | -1,157 | 99 | -2,692 | -1,412 | -2,390 | -1,009 |
Effect of translation of foreign denominated cash and cash equivalents and restricted cash | ||||||||
11 | 61 | 8 | -18 | -7 | 45 | -12 | 16 | 19 |
Net increase/(decrease) in cash and cash equivalents and restricted cash | ||||||||
164 | -196 | 105 | 10 | 120 | -89 | 104 | -101 | 136 |